Home NDC 50383-700 Fluticasone Propionate
Product NDC 50383-700
11-digit product format 503830700
Labeler code 50383
Product ID 50383-700_4f61c3c9-e855-4c87-a257-ed2860c866e3
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Fluticasone Propionate
Dosage form SPRAY, METERED
Route NASAL
Labeler Akorn
Application ANDA077570
Marketing category ANDA
Marketing start 2008-01-16
Marketing end 0000-00-00
Substance FLUTICASONE PROPIONATE
Active strength 50 ug/.1g
Pharmacologic classes Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC]
NDC exclude flag No
Listing certified through 2023-12-31
Current FDA listing Historical FDA.report record Observed NDC auxiliary status history# This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
Historic NDC status page 1 of 1 · 45 matching rows.
View current auxiliary records. · View the auxiliary file history.
Captured / source date, Dataset, Scope table Captured / source date Dataset Scope Package NDC Code Status Snapshot Source SHA-256 2025-12-14 17:58 UTC · source 2025-12-05 excluded product product D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 50383-700-16 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-12-14 17:58 UTC · source 2025-12-05 excluded package package 50383-700-09 D Discontinued by firm d630ba8d3edf…732f749b63fb…2025-08-27 00:01 UTC · source 2025-08-26 excluded product product I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 50383-700-16 I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-08-27 00:01 UTC · source 2025-08-26 excluded package package 50383-700-09 I Inactivated by FDA f5e01cc5f278…a2eaf40c39c3…2025-04-01 02:39 UTC · source 2025-03-31 excluded product product I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 50383-700-16 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-04-01 02:39 UTC · source 2025-03-31 excluded package package 50383-700-09 I Inactivated by FDA 2ef7874e63bc…57b86245f4fa…2025-03-28 20:22 UTC · source 2025-03-28 excluded product product I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 50383-700-16 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-28 20:22 UTC · source 2025-03-28 excluded package package 50383-700-09 I Inactivated by FDA a1b67e2a42f9…c4cf2c586c0d…2025-03-22 03:12 UTC · source 2025-03-21 excluded product product I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 50383-700-16 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-22 03:12 UTC · source 2025-03-21 excluded package package 50383-700-09 I Inactivated by FDA cfe11265f3b6…090c488252e2…2025-03-10 12:48 UTC · source 2025-03-10 excluded product product I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 50383-700-16 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-03-10 12:48 UTC · source 2025-03-10 excluded package package 50383-700-09 I Inactivated by FDA cdf11ea48f46…ba0047e9e063…2025-02-02 03:52 UTC · source 2025-01-31 excluded product product I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 50383-700-16 I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-02-02 03:52 UTC · source 2025-01-31 excluded package package 50383-700-09 I Inactivated by FDA 302b2466d912…e7b80fea0513…2025-01-20 13:05 UTC · source 2025-01-20 excluded product product I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 50383-700-16 I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-20 13:05 UTC · source 2025-01-20 excluded package package 50383-700-09 I Inactivated by FDA ed331223b511…672a5bd82f5f…2025-01-11 03:41 UTC · source 2025-01-10 excluded product product I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 50383-700-16 I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2025-01-11 03:41 UTC · source 2025-01-10 excluded package package 50383-700-09 I Inactivated by FDA 0efc9e666f02…f202fb6c5f17…2024-11-09 02:27 UTC · source 2024-11-08 excluded product product I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 50383-700-16 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-11-09 02:27 UTC · source 2024-11-08 excluded package package 50383-700-09 I Inactivated by FDA ad56d346431e…cc804d4bbf1e…2024-10-04 04:10 UTC · source 2024-10-03 excluded product product I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 50383-700-16 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-10-04 04:10 UTC · source 2024-10-03 excluded package package 50383-700-09 I Inactivated by FDA 367a005e9d99…383a685ebd0f…2024-07-10 04:00 UTC · source 2024-07-09 excluded product product I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 50383-700-16 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-07-10 04:00 UTC · source 2024-07-09 excluded package package 50383-700-09 I Inactivated by FDA 557ba5c1ecfa…9c80585c8c6e…2024-05-28 21:12 UTC · source 2024-05-28 excluded product product I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 50383-700-16 I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-28 21:12 UTC · source 2024-05-28 excluded package package 50383-700-09 I Inactivated by FDA 8af77b9d5b6f…d9bbb34c5368…2024-05-15 03:39 UTC · source 2024-05-14 excluded product product I Inactivated by FDA 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 50383-700-16 I Inactivated by FDA 834df4deac94…adcc014656a3…2024-05-15 03:39 UTC · source 2024-05-14 excluded package package 50383-700-09 I Inactivated by FDA 834df4deac94…adcc014656a3…2024-03-11 06:39 UTC · source 2024-03-08 excluded product product I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 50383-700-16 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…2024-03-11 06:39 UTC · source 2024-03-08 excluded package package 50383-700-09 I Inactivated by FDA 1332a3947898…d4bfe170f9cd…
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A077570-001 FLUTICASONE PROPIONATE FLUTICASONE PROPIONATE 0.05MG/SPRAY SPRAY, METERED / NASAL 2008-01-16
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 42 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A077570-001 FLUTICASONE PROPIONATE 0.05MG/SPRAY SPRAY, METERED / NASAL 2008-01-16 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A077570-001 FLUTICASONE PROPIONATE 0.05MG/SPRAY SPRAY, METERED / NASAL 2008-01-16 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A077570-001 FLUTICASONE PROPIONATE 0.05MG/SPRAY SPRAY, METERED / NASAL 2008-01-16 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A077570-001 FLUTICASONE PROPIONATE 0.05MG/SPRAY SPRAY, METERED / NASAL 2008-01-16 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A077570-001 FLUTICASONE PROPIONATE 0.05MG/SPRAY SPRAY, METERED / NASAL 2008-01-16 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A077570-001 FLUTICASONE PROPIONATE 0.05MG/SPRAY SPRAY, METERED / NASAL 2008-01-16 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A077570-001 FLUTICASONE PROPIONATE 0.05MG/SPRAY SPRAY, METERED / NASAL 2008-01-16 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A077570-001 FLUTICASONE PROPIONATE 0.05MG/SPRAY SPRAY, METERED / NASAL 2008-01-16 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A077570-001 FLUTICASONE PROPIONATE 0.05MG/SPRAY SPRAY, METERED / NASAL 2008-01-16 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A077570-001 FLUTICASONE PROPIONATE 0.05MG/SPRAY SPRAY, METERED / NASAL 2008-01-16 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A077570-001 FLUTICASONE PROPIONATE 0.05MG/SPRAY SPRAY, METERED / NASAL 2008-01-16 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A077570-001 FLUTICASONE PROPIONATE 0.05MG/SPRAY SPRAY, METERED / NASAL 2008-01-16 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A077570-001 FLUTICASONE PROPIONATE 0.05MG/SPRAY SPRAY, METERED / NASAL 2008-01-16 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A077570-001 FLUTICASONE PROPIONATE 0.05MG/SPRAY SPRAY, METERED / NASAL 2008-01-16 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A077570-001 FLUTICASONE PROPIONATE 0.05MG/SPRAY SPRAY, METERED / NASAL 2008-01-16 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A077570-001 FLUTICASONE PROPIONATE 0.05MG/SPRAY SPRAY, METERED / NASAL AB 2008-01-16 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A077570-001 FLUTICASONE PROPIONATE 0.05MG/SPRAY SPRAY, METERED / NASAL AB 2008-01-16 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A077570-001 FLUTICASONE PROPIONATE 0.05MG/SPRAY SPRAY, METERED / NASAL AB 2008-01-16 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A077570-001 FLUTICASONE PROPIONATE 0.05MG/SPRAY SPRAY, METERED / NASAL AB 2008-01-16 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A077570-001 FLUTICASONE PROPIONATE 0.05MG/SPRAY SPRAY, METERED / NASAL AB 2008-01-16 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A077570-001 FLUTICASONE PROPIONATE 0.05MG/SPRAY SPRAY, METERED / NASAL AB 2008-01-16 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A077570-001 FLUTICASONE PROPIONATE 0.05MG/SPRAY SPRAY, METERED / NASAL AB 2008-01-16 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A077570-001 FLUTICASONE PROPIONATE 0.05MG/SPRAY SPRAY, METERED / NASAL AB 2008-01-16 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A077570-001 FLUTICASONE PROPIONATE 0.05MG/SPRAY SPRAY, METERED / NASAL AB 2008-01-16 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A077570-001 FLUTICASONE PROPIONATE 0.05MG/SPRAY SPRAY, METERED / NASAL AB 2008-01-16 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A077570-001 FLUTICASONE PROPIONATE 0.05MG/SPRAY SPRAY, METERED / NASAL AB 2008-01-16 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A077570-001 FLUTICASONE PROPIONATE 0.05MG/SPRAY SPRAY, METERED / NASAL AB 2008-01-16 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A077570-001 FLUTICASONE PROPIONATE 0.05MG/SPRAY SPRAY, METERED / NASAL AB 2008-01-16 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A077570-001 FLUTICASONE PROPIONATE 0.05MG/SPRAY SPRAY, METERED / NASAL AB 2008-01-16 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A077570-001 FLUTICASONE PROPIONATE 0.05MG/SPRAY SPRAY, METERED / NASAL AB 2008-01-16 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A077570-001 FLUTICASONE PROPIONATE 0.05MG/SPRAY SPRAY, METERED / NASAL AB 2008-01-16 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A077570-001 FLUTICASONE PROPIONATE 0.05MG/SPRAY SPRAY, METERED / NASAL AB 2008-01-16 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A077570-001 FLUTICASONE PROPIONATE 0.05MG/SPRAY SPRAY, METERED / NASAL AB 2008-01-16 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A077570-001 FLUTICASONE PROPIONATE 0.05MG/SPRAY SPRAY, METERED / NASAL AB 2008-01-16 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A077570-001 FLUTICASONE PROPIONATE 0.05MG/SPRAY SPRAY, METERED / NASAL AB 2008-01-16 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A077570-001 FLUTICASONE PROPIONATE 0.05MG/SPRAY SPRAY, METERED / NASAL AB 2008-01-16 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A077570-001 FLUTICASONE PROPIONATE 0.05MG/SPRAY SPRAY, METERED / NASAL AB 2008-01-16 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A077570-001 FLUTICASONE PROPIONATE 0.05MG/SPRAY SPRAY, METERED / NASAL AB 2008-01-16 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A077570-001 FLUTICASONE PROPIONATE 0.05MG/SPRAY SPRAY, METERED / NASAL AB 2008-01-16 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A077570-001 FLUTICASONE PROPIONATE 0.05MG/SPRAY SPRAY, METERED / NASAL AB 2008-01-16 e64feba35796…
Observed Orange Book normalized TE history# DailyMed Product Concepts# FDA-Initiated Inactive NDC Indexing# NDC, Effective, Related label table NDC Effective Related label 50383-700-09 2025-09-10 These highlights do not include all the information needed to use Fluticasone Propionate Nasal Spray, USP safely and effectively. See full prescribing information for Fluticasone Propionate Nasal Spray, USP. Fluticasone Propionate nasal spray, USP, 50 mcg FOR INTRANASAL USE Initial U.S. Approval: 1994 50383-700-16 2025-09-10 These highlights do not include all the information needed to use Fluticasone Propionate Nasal Spray, USP safely and effectively. See full prescribing information for Fluticasone Propionate Nasal Spray, USP. Fluticasone Propionate nasal spray, USP, 50 mcg FOR INTRANASAL USE Initial U.S. Approval: 1994 50383-700-09 2024-01-30 These highlights do not include all the information needed to use Fluticasone Propionate Nasal Spray, USP safely and effectively. See full prescribing information for Fluticasone Propionate Nasal Spray, USP. Fluticasone Propionate nasal spray, USP, 50 mcg FOR INTRANASAL USE Initial U.S. Approval: 1994 50383-700-16 2024-01-30 These highlights do not include all the information needed to use Fluticasone Propionate Nasal Spray, USP safely and effectively. See full prescribing information for Fluticasone Propionate Nasal Spray, USP. Fluticasone Propionate nasal spray, USP, 50 mcg FOR INTRANASAL USE Initial U.S. Approval: 1994
DailyMed Socrata Ingredients# Ingredient, Type, UNII table Ingredient Type UNII DailyMed label SPL version Uploaded FLUTICASONE PROPIONATE ACTIVE INGREDIENT O2GMZ0LF5W FLUTICASONE PROPIONATE SPRAY, METERED [HI-TECH PHARMACAL CO., INC.] 6 FLUTICASONE ACTIVE MOIETY CUT2W21N7U FLUTICASONE PROPIONATE SPRAY, METERED [HI-TECH PHARMACAL CO., INC.] 6 BENZALKONIUM CHLORIDE INACTIVE INGREDIENT F5UM2KM3W7 FLUTICASONE PROPIONATE SPRAY, METERED [HI-TECH PHARMACAL CO., INC.] 6 CARBOXYMETHYLCELLULOSE SODIUM INACTIVE INGREDIENT K679OBS311 FLUTICASONE PROPIONATE SPRAY, METERED [HI-TECH PHARMACAL CO., INC.] 6 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U FLUTICASONE PROPIONATE SPRAY, METERED [HI-TECH PHARMACAL CO., INC.] 6 DEXTROSE INACTIVE INGREDIENT IY9XDZ35W2 FLUTICASONE PROPIONATE SPRAY, METERED [HI-TECH PHARMACAL CO., INC.] 6 PHENYLETHYL ALCOHOL INACTIVE INGREDIENT ML9LGA7468 FLUTICASONE PROPIONATE SPRAY, METERED [HI-TECH PHARMACAL CO., INC.] 6 POLYSORBATE 80 INACTIVE INGREDIENT 6OZP39ZG8H FLUTICASONE PROPIONATE SPRAY, METERED [HI-TECH PHARMACAL CO., INC.] 6 WATER INACTIVE INGREDIENT 059QF0KO0R FLUTICASONE PROPIONATE SPRAY, METERED [HI-TECH PHARMACAL CO., INC.] 6 FLUTICASONE PROPIONATE ACTIVE INGREDIENT O2GMZ0LF5W FLUTICASONE PROPIONATE SPRAY, METERED [UNIT DOSE SERVICES] 2 FLUTICASONE ACTIVE MOIETY CUT2W21N7U FLUTICASONE PROPIONATE SPRAY, METERED [UNIT DOSE SERVICES] 2 BENZALKONIUM CHLORIDE INACTIVE INGREDIENT F5UM2KM3W7 FLUTICASONE PROPIONATE SPRAY, METERED [UNIT DOSE SERVICES] 2 CARBOXYMETHYLCELLULOSE SODIUM INACTIVE INGREDIENT K679OBS311 FLUTICASONE PROPIONATE SPRAY, METERED [UNIT DOSE SERVICES] 2 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U FLUTICASONE PROPIONATE SPRAY, METERED [UNIT DOSE SERVICES] 2 DEXTROSE INACTIVE INGREDIENT IY9XDZ35W2 FLUTICASONE PROPIONATE SPRAY, METERED [UNIT DOSE SERVICES] 2 PHENYLETHYL ALCOHOL INACTIVE INGREDIENT ML9LGA7468 FLUTICASONE PROPIONATE SPRAY, METERED [UNIT DOSE SERVICES] 2 POLYSORBATE 80 INACTIVE INGREDIENT 6OZP39ZG8H FLUTICASONE PROPIONATE SPRAY, METERED [UNIT DOSE SERVICES] 2 WATER INACTIVE INGREDIENT 059QF0KO0R FLUTICASONE PROPIONATE SPRAY, METERED [UNIT DOSE SERVICES] 2 FLUTICASONE PROPIONATE ACTIVE INGREDIENT O2GMZ0LF5W FLUTICASONE PROPIONATE SPRAY, METERED [REBEL DISTRIBUTORS CORP] 1 FLUTICASONE PROPIONATE ACTIVE INGREDIENT O2GMZ0LF5W FLUTICASONE SPRAY, METERED [DIRECT RX] 1 FLUTICASONE PROPIONATE ACTIVE INGREDIENT O2GMZ0LF5W FLUTICASONE PROPIONATE SPRAY, METERED [PROFICIENT RX LP] 1 FLUTICASONE PROPIONATE ACTIVE INGREDIENT O2GMZ0LF5W FLUTICASONE PROPIONATE SPRAY, METERED [PREFERRED PHARMACEUTICALS, INC] 1 FLUTICASONE ACTIVE MOIETY CUT2W21N7U FLUTICASONE PROPIONATE SPRAY, METERED [PROFICIENT RX LP] 1 FLUTICASONE ACTIVE MOIETY CUT2W21N7U FLUTICASONE PROPIONATE SPRAY, METERED [REBEL DISTRIBUTORS CORP] 1 FLUTICASONE ACTIVE MOIETY CUT2W21N7U FLUTICASONE PROPIONATE SPRAY, METERED [PREFERRED PHARMACEUTICALS, INC] 1 FLUTICASONE ACTIVE MOIETY CUT2W21N7U FLUTICASONE SPRAY, METERED [DIRECT RX] 1 Anhydrous Dextrose INACTIVE INGREDIENT 5SL0G7R0OK FLUTICASONE SPRAY, METERED [DIRECT RX] 1 BENZALKONIUM CHLORIDE INACTIVE INGREDIENT F5UM2KM3W7 FLUTICASONE PROPIONATE SPRAY, METERED [REBEL DISTRIBUTORS CORP] 1 BENZALKONIUM CHLORIDE INACTIVE INGREDIENT F5UM2KM3W7 FLUTICASONE PROPIONATE SPRAY, METERED [PROFICIENT RX LP] 1 Benzalkonium Chloride INACTIVE INGREDIENT F5UM2KM3W7 FLUTICASONE SPRAY, METERED [DIRECT RX] 1 BENZALKONIUM CHLORIDE INACTIVE INGREDIENT F5UM2KM3W7 FLUTICASONE PROPIONATE SPRAY, METERED [PREFERRED PHARMACEUTICALS, INC] 1 CARBOXYMETHYLCELLULOSE SODIUM INACTIVE INGREDIENT K679OBS311 FLUTICASONE PROPIONATE SPRAY, METERED [REBEL DISTRIBUTORS CORP] 1 CARBOXYMETHYLCELLULOSE SODIUM INACTIVE INGREDIENT K679OBS311 FLUTICASONE PROPIONATE SPRAY, METERED [PROFICIENT RX LP] 1 carboxymethylcellulose sodium INACTIVE INGREDIENT K679OBS311 FLUTICASONE SPRAY, METERED [DIRECT RX] 1 CARBOXYMETHYLCELLULOSE SODIUM INACTIVE INGREDIENT K679OBS311 FLUTICASONE PROPIONATE SPRAY, METERED [PREFERRED PHARMACEUTICALS, INC] 1 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U FLUTICASONE PROPIONATE SPRAY, METERED [REBEL DISTRIBUTORS CORP] 1 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U FLUTICASONE PROPIONATE SPRAY, METERED [PREFERRED PHARMACEUTICALS, INC] 1 CELLULOSE, MICROCRYSTALLINE INACTIVE INGREDIENT OP1R32D61U FLUTICASONE PROPIONATE SPRAY, METERED [PROFICIENT RX LP] 1 DEXTROSE INACTIVE INGREDIENT IY9XDZ35W2 FLUTICASONE PROPIONATE SPRAY, METERED [REBEL DISTRIBUTORS CORP] 1 DEXTROSE INACTIVE INGREDIENT IY9XDZ35W2 FLUTICASONE PROPIONATE SPRAY, METERED [PREFERRED PHARMACEUTICALS, INC] 1 DEXTROSE INACTIVE INGREDIENT IY9XDZ35W2 FLUTICASONE PROPIONATE SPRAY, METERED [PROFICIENT RX LP] 1 PHENETHYL ALCOHOL INACTIVE INGREDIENT ML9LGA7468 FLUTICASONE PROPIONATE SPRAY, METERED [REBEL DISTRIBUTORS CORP] 1 PHENYLETHYL ALCOHOL INACTIVE INGREDIENT ML9LGA7468 FLUTICASONE PROPIONATE SPRAY, METERED [PROFICIENT RX LP] 1 PHENYLETHYL ALCOHOL INACTIVE INGREDIENT ML9LGA7468 FLUTICASONE PROPIONATE SPRAY, METERED [PREFERRED PHARMACEUTICALS, INC] 1 Phenylethyl Alcohol INACTIVE INGREDIENT ML9LGA7468 FLUTICASONE SPRAY, METERED [DIRECT RX] 1 POLYSORBATE 80 INACTIVE INGREDIENT 6OZP39ZG8H FLUTICASONE PROPIONATE SPRAY, METERED [PROFICIENT RX LP] 1 POLYSORBATE 80 INACTIVE INGREDIENT 6OZP39ZG8H FLUTICASONE PROPIONATE SPRAY, METERED [PREFERRED PHARMACEUTICALS, INC] 1 POLYSORBATE 80 INACTIVE INGREDIENT 6OZP39ZG8H FLUTICASONE PROPIONATE SPRAY, METERED [REBEL DISTRIBUTORS CORP] 1 Polysorbate 80 INACTIVE INGREDIENT 6OZP39ZG8H FLUTICASONE SPRAY, METERED [DIRECT RX] 1 WATER INACTIVE INGREDIENT 059QF0KO0R FLUTICASONE PROPIONATE SPRAY, METERED [PROFICIENT RX LP] 1 WATER INACTIVE INGREDIENT 059QF0KO0R FLUTICASONE PROPIONATE SPRAY, METERED [PREFERRED PHARMACEUTICALS, INC] 1 WATER INACTIVE INGREDIENT 059QF0KO0R FLUTICASONE PROPIONATE SPRAY, METERED [REBEL DISTRIBUTORS CORP] 1 Water INACTIVE INGREDIENT 059QF0KO0R FLUTICASONE SPRAY, METERED [DIRECT RX] 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 50383-700 FLUTICASONE PROPIONATE SPRAY, METERED [AKORN] 12 Legacy NDC 20220315_b7ea1841-2fb1-48c8-86f9-639893fd1a84.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Marketing start Marketing end Sample Exclude flag Status 50383-700-09 50383070009 1 BOTTLE, PUMP in 1 BOTTLE, PUMP (50383-700-09) > 9 g in 1 BOTTLE, PUMP 2016-01-08 0000-00-00 No No Current 50383-700-16 50383070016 1 BOTTLE, PUMP in 1 CARTON (50383-700-16) > 16 g in 1 BOTTLE, PUMP 2008-01-16 0000-00-00 No No Current